Vast Resources (VAST) reported improved third-quarter performance from its Aprelevka joint venture in Tajikistan, with gold ...
ECR Minerals (ECR ) has discovered coarse gold at the Brothers Mining Licence area in Queensland. Prospecting using metal ...
Poolbeg Pharma (POLB) has secured a South Korean patent covering POLB 001 and the use of p38 MAP kinase inhibitors to prevent ...
MedPal AI (MPAL) said September trading delivered further strong growth, taking its annualised revenue run rate to more than ...
BT Group, Coinsilium, EnSilica, First Class Metals, Hercules, Neo Energy, Pulsar Helium, Smarter Web, Tap Global ...
Rome continues to advance the Kalayi and Mont Agoma projects in the Democratic Republic of Congo, as well as its new project ...
KEFI Gold and Copper (KEFI) booked a loss of £4.6 million in the six months to June 2026. It has been an eventful year for ...
Panther's share price has more than doubled since the start of the year, as it has made progress on several fronts ...
Quantum Data Energy CEO Pieter Krügel discusses the restoration of trading in the company’s shares, the circumstances behind the temporary suspension and the outcome of the completed audit. He also ...
Hannam & Partners has maintained its 16.4p per share risked net asset value for Prospex Energy (PXEN) following a site visit to the company’s Dunajec licence in southern Poland, with the broker ...
In a statement to accompany today’s AGM, Cohort reports that trading in the year to date has been consistent with the Board’s expectations; the FY27 outlook remains unchanged, with the customary H2 ...
Poolbeg Pharma has announced a positive interim safety review from the TOPICAL clinical trial of POLB 001, with the study recommended to continue as planned and no changes required to the protocol.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results